- Tennessee hospitals name chief nursing officer
- MaineHealth protests bill to cap hospital procedure costs
- 10 places hiring anesthesiologists
- Health system CEOs keep ‘foot on the accelerator’ in gun violence prevention
- Outpatient interventional radiology clinic expands access in rural Georgia
- Clover 1st payer live on CMS-aligned network for interoperability
- Hospital drug prices vary widely, advocacy tool shows
- Surgery Partners acquires vascular ASC operator
- California hospital taps new chief operating and strategy officer
- CMS lifts Mission Hospital’s immediate jeopardy status
- Inside Mayo Clinic’s newest startup cohort
- Albany Medical Center names new hospital CEO
- CVS Health, Google Cloud to launch healthcare engagement platform
- Vanderbilt Health raises operating margin to 5.4% in H1
- GLP-1 drugs tied to lower addiction risk: Study
- The physician deals that defined 2025
- The colorectal cancer surgeon shortage by state, by 2036
- Rochester Regional Health to lay off coders at 2 hospitals: SEIU
- TriHealth expands heart care into primary care clinics
- 17 health systems with strong finances
- The ‘death spiral’ facing some Pennsylvania hospitals
- Kaiser behavioral health workers plan 1-day strike
- RadNet Acquires Gleamer to Support Position as a Radiology Clinical AI Solutions Leader
- RadNet Acquires Gleamer to Support Position as a Radiology Clinical AI Solutions Leader
- Ultrasound AI Receives FDA De Novo Clearance for Delivery Date AI Technology
- Ultrasound AI Receives FDA De Novo Clearance for Delivery Date AI Technology
- Abbott CardioMEMS™ remote heart failure monitoring reader receives FDA approval
- Abbott CardioMEMS™ remote heart failure monitoring reader receives FDA approval
- BD Gets CE Mark for Revello Vascular Covered Stent
- BD Gets CE Mark for Revello Vascular Covered Stent
- Testosterone Therapy Could Mean Trouble For Knee Replacement Patients, Study Warns
- Dentists Can Help Detect Undiagnosed Diabetes, Study Argues
- Ultra-Processed Foods Linked To Emotional, Behavioral Problems In Preschoolers
- Study Links Rising Cannabis Use to Poor Mental Health
- Fitness Trackers Might Help Predict Multiple Sclerosis Progression
- After generic defense fails, Merck KGaA assumes no US Mavenclad sales after March
- Half of Americans Unaware of At-Home Colon Cancer Screening Options
- Galderma doubles Nemluvio peak sales projection to $4B-plus after strong atopic dermatitis launch year
- Leo roars onto Netflix with DTC campaign for new hand eczema cream Anzupgo
- As ICE Moved In, Minnesotans Set Up a Shadow Medical System. It’s a Lesson for Other Cities.
- Con la presencia del ICE, habitantes de Minnesota crearon un sistema médico en las sombras. Un aprendizaje para otras ciudades
- Listen: What To Do When Health Insurance Slips Out of Reach
- Trump’s Cuts to Medicaid Threaten Services That Help Disabled People Live at Home
- Essentia Health shifts recreational therapists to tech roles; union protests changes
- Texas oral surgery practice opens 2 locations
- How 3 insurers are trying to tighten E/M billing oversight
- Texas orthodontics practices merge
- Network Health, backed by Cost Plus partnership, posts another year of record Medicare Advantage growth
- AWS offers agentic AI solution to tackle scheduling, ambient note-taking and medical coding
- Appeals court could revive cardiologist’s anti-DEI retaliation lawsuit
- Mistrial declared in Virginia unlicensed dentistry case
- GI cancers to double by 2050: Report
- What It Takes to Deploy AI at Scale in Dentistry—and Why It Matters
- California system moves to delay layoffs
- Why Prisma Health is betting big on outpatient expansion
- Anesthesia reimbursement declines over the last 5 years
- Federal resolution introduced to back fluoride use
- Salt Dental Partners expands in 3 states
- UPMC gifted $1.25M to support care in North Central Pennsylvania
- NYC Health + Hospitals advances behavioral health strategy: 4 things to know
- Opening Remarks at Private Markets Roundtable
- Eli Lilly launches its direct-to-employer platform for obesity drugs
- Eli Lilly launches its direct-to-employer platform for obesity drugs
- Rhode Island lawmaker pushes for creation of new dental school: 6 notes
- Hospitals decry drugmakers' expanded claims reporting policies for 340B
- CMS releases toolkit for children’s behavioral health services
- CVS unveils Health 100, its new Google-powered consumer engagement platform
- Qventus Launches Care Gap and Coding Automation Suite to Improve Patient Care and Reimbursement Revenue
- Dental therapist bill fails in Florida Senate
- Straine Dental Management adds 6th Texas practice
- Newport Healthcare taps chief growth and experience officer
- Independent autism research committee forms amid concerns over federal panel
- 12 health systems seeking revenue cycle vice presidents
- Remarks at Financial Stability Oversight Council Artificial Intelligence Innovation Series Roundtable on Strategy and Governance Principles
- Collegium enrolls Paris Hilton in Jornay PM push encouraging ADHD community to 'Embrace Your Sparkle'
- Review of U.S. Measles Elimination Status Delayed Until November
- Your Furry Roommate May Be Affecting The Air You Breathe
- BioDuro enters Taiwan joint venture, adding commercial API plant to production network
- FDA answers Vanda's yearslong call for public hearing on unsuccessful jet lag approval bid
- MUSC Health acquires South Carolina's largest multispecialty practice for $111M
- About 81,000 Baby Monitors Recalled Over Possible Fire Risk
- Armed with funding and an acquisition, Procode AI launches AI-powered RCM for surgical billing
- Charities merge to form nation's 'most comprehensive' patient assistance nonprofit
- Two Days of Oatmeal May Lower Cholesterol, Study Finds
- Bayer looking at another year of 'resilience' before growth kicks in behind Nubeqa, Kerendia
- Colorectal Cancer Rates Shifting to Younger Groups as Rectal Cancer Rates Spike
- Brain Chemical Provides A 'Pep In Your Step,' Experiment Shows
- Lithium Might Slow Brain Decline Among Seniors, Pilot Study Shows
- Exercise Boosts Quality of Life During Breast Cancer Chemotherapy
- Early Sports Specialization Linked To Increased Injury Risk
- More Kids, Teens Injured In E-Bike Wrecks, Study Finds
- Novo lands another FDA untitled letter, this time for Apple-inspired Ozempic ad
- Moderna fronts $950M to settle yearslong COVID patent litigation with Genevant, Arbutus
- Despite Their Successes, Some Mobile Crisis Response Teams Are in Crisis
- Lawmakers, Health Groups Resist Their States’ Rural Health Fund Plans
- Healthcare’s mixed Q4, plus insights from the Lake Nona Impact Forum
- Danish agency NoA Health names new CEO to drive global expansion
- Sanofi strikes $1.5B global licensing deal for Sino Biopharm's first-in-class JAK/ROCK asset
- Bassett Healthcare Network appoints division chief of dental services
- Aetna fined $550K for mental health parity violations
- California provider opens teen mental health center
- Inside Huntsman’s hybrid model boosting social worker capacity sixfold
- FDA ramps up crackdown on GLP-1 drug compounding with fresh batch of 30 warning letters
- FDA ramps up crackdown on GLP-1 drug compounding with fresh batch of 30 warning letters
- HCA Healthcare says all-time high inpatient occupancy, ACA exchange attrition won't spoil 2026 volume growth
- Pfizer CEO Albert Bourla on FDA official Vinay Prasad: 'We have a problem with the leadership of CBER'
- Ireland’s biopharma appeal holds up amid unsteady geopolitical backdrop, US investment blitz
- Papa rolls out new program for insurers called Papa Plus
- AI Therapist? It Falls Short, a New Study Warns
- Grow Therapy scores $150M to build out enterprise partnerships with docs, employers
- Rising Stars: Boehringer’s Chris Kraemer on the power of patient impact
- Nearly 20 States Scale Back HIV Medication Programs
- BBQ Sauce Recall Issued Nationwide Due To Incorrect Label
- FDA Recalls More Than 651,000 Jugs of Water Over Sanitation Concerns
- Listen to the Latest ‘KFF Health News Minute’
- Hasta los pacientes se sorprenden por los precios que sus aseguradoras están dispuestas a pagar, un costo que al final pagamos todos
- Patients with multiple chronic diseases are a looming threat to health systems' financials: Vizient
- Guardant picks Patrick Dempsey for colorectal cancer blood test awareness
- Breast Cancer Cases, Deaths Expected To Rise Worldwide
- Collagen Supplements Good For Skin, Arthritis, Evidence Review Concludes
- Illicit Adderall Use Places Stress On The Heart, Study Shows
- A-Fib Drug, Diltiazem, Could Interact With Blood Thinners, Increase Risk Of Dangerous Bleeding
- How to Get Ready For Daylight Saving Time
- Effective Sunscreen Protection Can Cost $40 A Year
- Longtime Cigna CEO David Cordani to retire, Brian Evanko tapped as successor
- Acadia, undaunted by recent EU rejection, seeks CHMP re-examination of Rett syndrome med Daybue
- FDA’s CRLs reveal critical errors in AstraZeneca’s Saphnelo data, efficacy doubts for GSK’s Exdensur
- Even Patients Are Shocked by the Prices Their Insurers Will Pay — And It Costs All of Us
- Readers Lean On Congress To Solve Crises in Research and Rehab
- Disc lays off 20% of employees to steady ship after FDA rejection of rare disease drug
- Novo plugs $500M into Ireland plant to produce Wegovy pill for markets outside US
- Esperion pays $75M-plus to acquire Corstasis and newly approved Enbumyst
- In 1 state, large hospitals dominate 340B's net savings
- HHS bans Claude AI tool as Trump seeks full government blacklisting of Anthropic
- Report: Most states investing in value-based care with Rural Health Transformation Program
- U.S. Tops 1,100 Measles Cases This Year as Outbreaks Grow
- FDA To Offer Cash Bonuses for Faster Drug Reviews
- Former Optum CEO Heather Cianfrocco to depart UnitedHealth Group
- New Drug, Acoziborole, Could Boost Efforts to Wipe Out Sleeping Sickness
- Chocolate Male Supplement Recalled Over Hidden Erectile Dysfunction Drug
- CMS set to suspend enrollment in Elevance Health's Medicare Advantage plans
- Providers urge Education Department to reconsider which jobs face stiffer student loan caps
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Urban Traffic Noise Disrupts Sleep, Affects Heart Health After One Night
- Hormone Therapy Might Be Unnecessary For Some Prostate Cancer Patients
- Benzodiazepine Use Down In U.S., But OD Risk Remains, Study Says
- GLP-1 Drugs Might Ease Chronic Migraine, Study Says
- Blood Test Reveals Alcohol-Related Liver Disease
- Telemedicine Visits Cost Five Times Less Than In-Clinic Care
- Quest Diagnostics launches Google-powered AI chatbot to help patients understand lab results
Department of Health and Human Services Secretary Kennedy reconstituted the Interagency Autism Coordinating Committee (I-ACC) in January with 21 new public members. Now beginning their mandate, they have attacted a great deal of criticism from the establishment:
Kennedy's new US autism panel to examine potential causes
By Leah Douglas and Ahmed Aboulenein - March 5, 2026Summary
- New panel includes vaccine skeptics, raising concerns among autism experts
- Panel could explore controversial vaccine links
- Outside experts warn focus on vaccines may divert funds from other autism research
WASHINGTON, March 5 (Reuters) - A U.S. autism advisory board remade by Health Secretary Robert F. Kennedy Jr. to include vaccine skeptics aims to steer federal research spending toward investigating causes of the condition, as well as other issues like co-occurring medical disorders, according to some new panel members.
Kennedy, a longtime anti-vaccine activist who has suggested the inoculations cause autism, contrary to scientific evidence, reset the Interagency Autism Coordinating Committee in January with 21 new public members. More than a third of the new committee members have also promoted the debunked link between vaccines and autism.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Some autism experts, including former committee members, have said the new members could undermine federal autism research. This week, some former members created their own alternative advisory board, the latest in a series of similar efforts by public health experts concerned about Kennedy's overhaul of federal vaccine policy and what they see as misinformation coming from agencies he oversees.No rigorous studies have found links between autism and vaccines or medications. Autism experts attribute rising rates of the condition largely to more inclusive diagnosis criteria.
The committee, due to first meet on March 19, will provide non-binding guidance to Kennedy on federal autism research priorities, including recommendations on allocating hundreds of millions of dollars in research spending.
Kennedy has promised President Donald Trump he will identify the cause of autism, which most researchers suggest is linked in part to genetics and exposure in utero to pollutants or harmful contaminants. Many of Kennedy's supporters in the Make America Healthy Again movement - some of whom were named to the committee - also believe vaccines can cause autism and advocate for fewer childhood vaccinations.
Committee chair Sylvia Fogel, a psychiatrist and instructor at Harvard Medical School, told Reuters the committee will address gaps in autism research like causal triggers in an effort to better serve people with profound autism and their families.
"Autism is not monolithic. Federal strategy should reflect that complexity rather than flatten it," Fogel said.
Department of Health and Human Services spokesman Andrew Nixon said the new committee is meant to unite a range of voices and that "expanding perspectives on the panel does not change the fact that federal research is grounded in rigorous science."
SOME MEMBERS LINK VACCINES AND AUTISM
Until January's overhaul, major autism groups like the Simons Foundation and Autism Speaks, and researchers from universities including Johns Hopkins and Tufts accounted for most of the committee's 21 members from the public.
That panel recommended further research into co-occurring physical and behavioral health conditions, like epilepsy, gastrointestinal issues and anxiety disorders, according to a draft 2024 report.
David Sitcovsky, vice president of advocacy at Autism Speaks, said in a statement that broader representation would strengthen the committee, but that its impact would depend on retaining a grounding in science.
The new panel contains more activists, just three autistic self-advocates - the minimum required by law - down from seven, and few representatives from research universities. At least eight have tied vaccination to autism or are connected to organizations that support those claims, including several who say their children developed autism after being vaccinated, according to a Reuters review of their public statements and affiliations.
Panel member Ginger Taylor, who created a website called "How Do Vaccines Cause Autism?", wrote in a Substack post that her top priority for the committee is investigating the link between vaccines and autism.
John Gilmore, a new panel member and co-founder of the Autism Action Network who says his 26-year-old son developed autism after being vaccinated, said he wants to steer more research toward rising autism rates.
"A lot of the voices that are on the (committee) now have been deliberately excluded for 20-odd years," he said.
Several, including Gilmore and Fogel, appeared on panels at a September autism event hosted by the MAHA Institute, whose president, Mark Gorton, is an anti-vaccine activist and was a significant funder of Kennedy's 2024 presidential campaign.
Asked how some members' views on vaccines will affect the committee's work, Fogel said studies of the measles-mumps-rubella vaccine and thimerosal-containing vaccines have not shown a causal link to autism.
"That body of available evidence is substantial and must be acknowledged," Fogel said.
Still, research should examine how various exposures, including immune or inflammatory stress, might affect autism outcomes, she said.
EXPERT CONCERNS
On Tuesday, a dozen autism advocates, researchers and several former committee members formed the Independent Autism Coordination Committee to create its own strategic plan for autism research.
Alison Singer, president of the Autism Science Foundation and a prior government committee member, said investing federal dollars into researching a link between vaccines and autism, which most experts consider settled science, would cut into funding for other research opportunities, like autism's heritability or link to environmental exposures.
"There’s not a bottomless pit of money at the NIH that can be used to fund research," Singer said. "If we devote our very limited resources towards reinvestigating vaccines, we won’t have money to look at actual potential causes of autism."
More on the self appointed Independent Autism Coordinating Committee (I-ACC), with a deceitful name and acronym deliberately chosen to confuse the public into thinking that it is the official Interagency Autism Coordinating Committee (I-ACC):
Autism researchers rebuke Kennedy, form independent advisory group
The group wants to be a bulwark against potential misinformation from federal health agencies
By O. Rose Broderick - March 3, 2026A group of autism researchers and advocates announced Tuesday the formation of an independent advisory body that will develop a scientific agenda for the autism community. They hope to act as a bulwark against a federal committee bearing a similar name and its new members who believe that childhood vaccines can cause autism, despite the lack of evidence for such a link.
The Independent Autism Coordinating Committee (I-ACC) will hold its first meeting on March 19 — the same day that the newly-reformed federal body, the Interagency Autism Coordinating Committee (IACC), will meet for its first publicly-announced meeting, as first reported by the Washington Post.
The independent body’s leaders see their group and future actions as a direct rebuke of health secretary Robert F. Kennedy Jr. and his decision to refashion the federal body with members who align with his views on autism and vaccines, instead of preeminent researchers and autistic self-advocates.
“We don’t believe that the new federal IACC is going to pursue the kinds of areas and priorities that the mainstream scientific community feels are important at this point,” said Helen Tager-Flusberg, a member of the new group and director of the Center for Autism Research Excellence at Boston University.
The independent group includes many former members of the federal body, such as Joshua Gordon, former National Institute of Mental Health director, and Alison Singer, president of the Autism Science Foundation. The 12 members are mostly researchers, a contrast with the federal body, whose members mostly focus on advocacy.
Tager-Flusberg says the group will not rehash every matter the federal body considers, but they will primarily determine which topics within autism research deserve the most attention, with an eye on informing the decisions of non-governmental funders. The group will continue to meet whenever the federal body meets in an attempt to halt any misinformation that emerges from the meeting. If, for example, IACC plans to discuss vaccines and autism, the researchers will host a meeting and discuss the existing evidence on the topic on the same day.
When asked whether the similar names, meeting dates, and purported goals could sow confusion in the autism community about who to trust, she responded, “Are you going to pay attention to the group that contains not a single reputable scientist, or anyone experienced with conducting research? Or are you going to look at a group of people, which includes the people who have all the credentials that you would expect from the membership of the IACC?”
The Department of Health and Human Services has no plans to change the federal body’s proceedings in response to their independent counterpart. “The federal IACC will continue to fulfill President Trump’s directive to bring autism research to the 21st century and support breakthroughs in autism diagnosis, treatment, and prevention,” said Andrew Nixon, an HHS spokesperson.
This is not the first group of researchers and advocates who have formed their own advisory group as a bid to push back against misinformation from the federal government. The Vaccine Integrity Project launched last year as a means for assessing and disseminating the best available evidence on vaccines.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















